Vertex Pharmaceuticals Incorporated
4 clinical trials · 4 recruiting · INDUSTRY
Trials by Vertex Pharmaceuticals Incorporated
RECRUITINGPhase 1NCT07437105
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single and multiple ascending doses of VX-272.
Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 1281 location
Cystic Fibrosis
RECRUITINGPhase 1 / Phase 2NCT05668741
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
The purpose of this study is to evaluate the safety, and tolerability and efficacy of VX-522 in participants 18 years of age and older with cystic fibrosis and a cystic fibrosis...
Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 3920 locations
Cystic Fibrosis
RECRUITINGPhase 1NCT06154447
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 and VX-828 in triple combination (TC) with Tezacaftor (TEZ)/ VX-118 or TEZ/...
Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 25511 locations
Cystic Fibrosis
RECRUITINGPhase 1NCT07283770
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of single and multiple ascending doses of VX-581.
Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 1281 location
Cystic Fibrosis